You are leaving GSKSource to visit a separate website not associated with GSKSource, a portal for US Healthcare Professionals.There are website links to third-party sites on GSK Source.GSK is not responsible for content on third-party websites.
You must be registered with GSKSource in order to attend an Event/Webinar
Required fieldHealth Outcomes Liaison, Vaccines
Marcella has been with GSK since October 2014. Marcella is born and raised in Honolulu, HI and now resides in Portland, OR. She is married with 2 children. She earned her doctorate in pharmacy at the University of the Pacific in Stockton, CA and fellowship from the Executive Management Program for Pharmacy Leaders at the Wharton School, University of Pennsylvania. She’s held various board appointments within the state of Hawaii, as well faculty appointments for various schools of pharmacy. She has worked as a clinical pharmacist in the VA and Kaiser, medical outcomes specialist for industry. Prior to joining GSK she was a pharmacy director for a national managed Medicaid and Medicare health plan in the Hawaii market.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
Trademarks are property of their respective owners.
827007R0 October 2017
SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older.
SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).